Reuters reveals Singapore’s Temasek considers sale of Advanced MedTech, likely valued at about $1 bln | Reuters News Agency
Business & Finance

Reuters reveals Singapore’s Temasek considers sale of Advanced MedTech, likely valued at about $1 bln

Reuters was first to report Temasek Holdings is exploring selling Advanced MedTech, after the medical devices firm, fully owned by the Singaporean state investor, received interest from suitors, including buyout funds. Two investment banks have been tapped to launch a sale process for Singapore-headquartered MedTech, which could be valued at roughly $1 billion.

Article Tags
Topics of Interest: Business & Finance
Type: Reuters Best
Sectors: Business & Finance
Regions: Asia
Countries: Singapore
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
Temesak
Sign up for email updates
Subscribe
Sign up for email updates